Literature DB >> 58260

Role of gluten, prednisone, and azathioprine in non-responsive coeliac disease.

J D Hamilton, R A Chambers, A Wynn-Williams.   

Abstract

A case of severe "non-responsive" coeliac disease has been shown to be sensitive to gluten whilst under prednisone therapy, but not without prednisone. This adds an additional dimension to the criteria for diagnosis of coeliac disease. Cases of non-responsive coeliac disease may require both prednisone and gluten exclusion to induce a remission. In this patient, azathioprine induced and sustained a remission when unacceptably high doses of prednisone had failed, and may prove to be a valuable immunosuppressive in non-responsive coeliac disease.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 58260     DOI: 10.1016/s0140-6736(76)92162-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  12 in total

Review 1.  Pathogenesis of coeliac disease: implications for treatment.

Authors:  J S Fraser; P J Ciclitira
Journal:  World J Gastroenterol       Date:  2001-12       Impact factor: 5.742

Review 2.  Refractory sprue.

Authors:  Andrea N Culliford; Peter H R Green
Journal:  Curr Gastroenterol Rep       Date:  2003-10

Review 3.  Recent advances in the understanding of celiac disease: therapeutic implications for the management of pediatric patients.

Authors:  John H Kwon; Richard J Farrell
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

Review 4.  Refractory celiac disease.

Authors:  Hani Abdallah; Daniel Leffler; Melinda Dennis; Ciarán P Kelly
Journal:  Curr Gastroenterol Rep       Date:  2007-10

5.  Small intestinal ulceration: diagnostic difficulties in relation to coeliac disease.

Authors:  D A Robertson; M F Dixon; B B Scott; F G Simpson; M S Losowsky
Journal:  Gut       Date:  1983-06       Impact factor: 23.059

Review 6.  Lymphoma in coeliac disease.

Authors:  E M Mathus-Vliegen
Journal:  J R Soc Med       Date:  1995-12       Impact factor: 18.000

Review 7.  Update on Immune Checkpoint Inhibitor Enterocolitis.

Authors:  Molly R Kelly-Goss; Yousef R Badran; Michael Dougan
Journal:  Curr Gastroenterol Rep       Date:  2022-10-20

8.  Clinical staging and survival in refractory celiac disease: a single center experience.

Authors:  Alberto Rubio-Tapia; Darlene G Kelly; Brian D Lahr; Ahmet Dogan; Tsung-Teh Wu; Joseph A Murray
Journal:  Gastroenterology       Date:  2008-10-08       Impact factor: 22.682

9.  Celiac crisis in an adult on immunosuppressive therapy.

Authors:  Owayed Al Shammeri; Donald R Duerksen
Journal:  Can J Gastroenterol       Date:  2008-06       Impact factor: 3.522

10.  A pilot study of fluticasone propionate in untreated coeliac disease.

Authors:  H C Mitchison; H al Mardini; S Gillespie; M Laker; A Zaitoun; C O Record
Journal:  Gut       Date:  1991-03       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.